Latest news
First drug to treat dry AMD approved for use in US
Posted: Tuesday 21 February 2023
The first ever drug to treat dry age-related macular degeneration (AMD) has been approved for use in the US.
Find out more
New genomic technique could transform diagnosis and treatment for rare eye disease
Posted: Wednesday 15 February 2023
Scientist Dr Gavin Arno and clinician Dr Siying Li from Moorfields Eye Hospital, will be revealing more details about a new genomic technique which could transform diagnosis and treatment for rarer types of inherited eye diseases.
Find out more
How could your data play a part in the future of eye care?
Posted: Thursday 2 February 2023
Dr Wen Hwa Lee, chief executive officer and chief scientist of charity Action Against AMD (AAAMD), has shared more about how your data could play a part in the future of eye care.
Find out more
How could artificial intelligence transform eye care?
Posted: Wednesday 11 January 2023
Chief executive of Action Against Age-related Macular Degeneration Dr Wen Hwa Lee, will be joining our first webinar of the year to discuss the advances being made in AI and its potential in ophthalmology and research.
Find out more
New research funding for diabetic eye disease
Posted: Thursday 1 December 2022
Leading eye charities, including the Macular Society, have partnered with Diabetes UK to fund more research into diabetic eye disease and prevent unnecessary sight loss.
Find out more
Dry AMD patients respond to injection breakthrough studies
Posted: Friday 25 November 2022
Initial findings have shown the majority of people with late-stage dry age-related macular degeneration (AMD) would welcome eye injections as a way of slowing down its progress.
Find out more
Statins and diabetes drugs found to reduce risk of age-related macular degeneration
Posted: Tuesday 8 November 2022
Drugs to control diabetes and lower cholesterol may reduce the risk of developing age-related macular degeneration (AMD), a new study suggests.
Find out more
New partnership to accelerate research into macular disease
Posted: Monday 7 November 2022
Clinical research organisation Ora Inc has partnered with the Macular Society, to accelerate the advancement of new treatments for macular disease and help more patients take part in clinical trials.
Find out more
New research investigates immune system's role in AMD
Posted: Monday 31 October 2022
New research is looking into a specific part of the immune system, called the ‘complement system’, which, when damaged, can lead to age-related macular degeneration (AMD).
Find out more
Experts unite to find a cure for dry AMD
Posted: Friday 21 October 2022
Global experts in macular disease will meet in the US this month to speed up the progress being made to find a cure for dry age-related macular degeneration (AMD).
Find out more
Participants needed for Charles Bonnet research
Posted: Saturday 1 October 2022
Scientists want to understand more about how visual hallucinations caused by sight loss impact the daily lives of those affected.
Find out more
Drug shows potential to slow down dry AMD progression
Posted: Thursday 29 September 2022
A new drug being trialled in patients with dry age-related macular degeneration (AMD) has been shown to reduce the rate of progression of the disease in its late stages.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter